StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3018% below fair value
$310.55+3.74 (+1.22%)

Close on Nov 3, 2026Market cap $119.12BP/E 33.1Yield –

Stryker Standalone Sub-Portfolio: Neuro Cranial by Quarter

Standalone Sub-Portfolio: Neuro Cranial — Worldwide Net Sales ($M) ($M)

QuarterlyAnnual

Stryker Standalone Sub-Portfolio: Neuro Cranial: $670M in Q3 2026, up 5.2% from a year earlier.

Latest, Q3 2026
670
Period ended Sep 30, 2026
Change on a year earlier
+5.2%
637 in Q3 2025
History
24 quarters
Since Q4 2020
Sources
17
Documents cited below

Where the Q3 2026 figure comes from

“Instruments includes sales related to Neuro Cranial of $670 and $637 and Enabling Technologies of $28 and $45 for the three months”

Q4 2025 derived via FY − 9M on identical recast basis.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStandalone Sub-Portfolio: Neuro Cranial — Worldwide Net Sales ($M) ($M)Year on yearSource
Q3 2026Sep 30, 2026670+5.2%0000310764-26-000059|sykex991earningsq32026.htm ↗
Q2 2026Jun 30, 2026681+10.6%0000310764-26-000048|sykex991earningsq22026.htm ↗
Q1 2026Mar 31, 2026606+7.6%0000310764-26-000025|sykex991earningsq12026.htm ↗
Q4 2025Dec 31, 2025669+10.9%0000310764-26-000006|sykex991earningsq42025.htm ↗
Q3 2025Sep 30, 2025637+44.4%0000310764-26-000059|sykex991earningsq32026.htm ↗
Q2 2025Jun 30, 2025616+48.1%0000310764-26-000048|sykex991earningsq22026.htm ↗
Q1 2025Mar 31, 2025563+48.2%0000310764-26-000025|sykex991earningsq12026.htm ↗
Q4 2024Dec 31, 2024603+38.0%0000310764-25-000005|sykex991earningsq42024.htm ↗
Q3 2024Sep 30, 2024441+14.8%0000310764-24-000113|sykex991earningsq32024.htm ↗
Q2 2024Jun 30, 2024416+11.5%0000310764-24-000095|sykex991earningsq22024.htm ↗
Q1 2024Mar 31, 2024380+7.0%0000310764-24-000062|sykex991earningsq12024.htm ↗
Q4 2023Dec 31, 2023437+13.8%0000310764-24-000005|sykex991earningsq42023.htm ↗
Q3 2023Sep 30, 2023384+15.7%0000310764-23-000114|sykex991earningsq32023.htm ↗
Q2 2023Jun 30, 2023373+10.7%0000310764-23-000104|sykex991earningsq22023.htm ↗
Q1 2023Mar 31, 2023355+9.9%0000310764-23-000065|sykex991earningsq12023.htm ↗
Q4 2022Dec 31, 2022384+18.5%0000310764-23-000005|sykex991earningsq42022.htm ↗

Breakdown

What makes up standalone Sub-Portfolio: Neuro Cranial

Cite this data

StockData. (2026). Stryker Standalone Sub-Portfolio: Neuro Cranial ($M), quarterly Q4 2020–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/sub-neuro-cranial-ww

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?